Target intelligence / Profile preview

Leucine-rich repeat-containing protein 9 (LRRC9)

Target
LRRC9
Molecular classification
Other (Leucine-rich repeat-only protein; does not fall into established drug target classes like receptor, enzyme, channel, or transporter), Pseudoenzyme (contains an atypical, likely catalytically inactive, ART [ADP-ribosyltransferase]-like domain)
01

Overview

Leucine-rich repeat-containing protein 9 (LRRC9) is a human protein encoded by the LRRC9 gene. It features multiple leucine-rich repeats (LRR), a structural motif often associated with protein-protein interactions and signal transduction. LRRC9 lacks domains typical of canonical receptor, enzyme, or channel targets, and appears to function primarily as a multifunctional signaling adaptor. Bioinformatics analyses suggest it contains an atypical ADP-ribosyltransferase-like domain but lacks the residues necessary for enzymatic activity, suggesting a “pseudoenzyme” function. It is predicted to be involved in mRNA splicing via the spliceosome, may bind U2 snRNA, and is localized to the cytoplasm. Population genomics implicates LRRC9 in developmental and reproductive regulation (notably in some fish species), and it may serve as a link between environmental/pathogen detection and cell signaling in processes such as immune defense and development. There are currently no established roles for LRRC9 in human pathology, no drugs targeting it, and no evidence it is used as a biomarker or presents notable safety/therapeutic challenges.

Other names
LRRC9FLJ46156Leucine-rich repeat-containing 9
02

Mechanism of action

Not applicable (no known drugs or inhibitors)

03

Biological functions

mRNA splicing (via spliceosome)U2 snRNA binding (predicted)Signaling adaptor, potentially integrating immune, developmental, and behavioral signaling pathwaysDevelopmental regulation and possibly modulation of reproductive behaviorImmune defense (suggested by patterns of sequence and expression)
04

Disease associations

Other: Implicated in reproductive trait evolution in fish (sockeye salmon), but not directly in major human diseasesNo strong evidence for involvement in specific human disease categories (such as cancer, inflammation, neurodegeneration, etc.) as of now

Beyond the preview

Go deeper on Leucine-rich repeat-containing protein 9 (LRRC9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine-rich repeat-containing protein 9 (LRRC9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call